Levosimendan

Levosimendan
Product Description

Levosimendan indicated for short-term treatment of acutely decompensated severe chronic heart failure. Form & strength: 2.5mg/ml concentrate for solution for infusion 

PharmIdea

  • LV
  • 2015
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Manufacturer/Innovator
Specifications

PharmIdea

  • LV
  • 2015
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
Contract Service
Manufacturer/Innovator

More Products from PharmIdea (2)

  • Carbetocin

    Product Carbetocin

    Carbetocin indicated for the prevention of uterine atony following delivery of the infant by caesarean section under epidural or spinal anaesthesiaForm & strength: 100 mcg/ ml solution for injection
  • Caspofungin

    Product Caspofungin

    Caspofungin  powder for concentrate for solution for infusion
    50mg/vial
    70mg/vial
    Caspofungin is a new class of echinocandin antifungal agent with broad spectrum of activity used to treat a variety of fungal infections.

PharmIdea resources (1)

  • News New products for Out-Licensing

    Pharmidea offers completed CTD for Out-Licensing and contract manufacturing of Levosimendan 2.5mg/ ml concentrate for solution for infusion in small batch size, produced at EU GMP approved manufacturing site located in Latvia.